Zobrazeno 1 - 10
of 119 386
pro vyhledávání: '"relapsed/refractory"'
Autor:
Jiao, Ning1 (AUTHOR), Shi, Lina1 (AUTHOR), Wang, Shaohua2 (AUTHOR), Sun, Yonghao1 (AUTHOR), Bai, Yujun3 (AUTHOR), Zhang, Dengshan4 (AUTHOR) 18765331105@163.com
Publikováno v:
BMC Cancer. 4, Vol. 24 Issue 1, p1-13. 13p.
Autor:
Parekh, Deevyashali S.1 (AUTHOR) parekhd@upstate.edu, Tiger, Yun Kyoung Ryu2 (AUTHOR) yt467@cinj.rutgers.edu, Jamouss, Kevin Tony3 (AUTHOR) kevin.jamouss@baystatehealth.org, Hassani, Justin3 (AUTHOR) justin.hassani@baystatehealth.org, Bou Zerdan, Maroun1 (AUTHOR) bouzerdm@upstate.edu, Raza, Shahzad4 (AUTHOR) razas@ccf.org
Publikováno v:
Cancers. Sep2024, Vol. 16 Issue 17, p2931. 20p.
Publikováno v:
Chinese Journal of Oncology Prevention & Treatment. Oct2024, Vol. 16 Issue 5, p549-553. 5p.
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background As we delve into the intricate world of venetoclax combination therapy in relapsed or refractory acute myeloid leukemia (AML), our exploration not only aims to contribute to the current body of knowledge but also strives to inform
Externí odkaz:
https://doaj.org/article/c45798f47326429a914cb9f7c8578e0b
Autor:
Mohseni, Rashin1 (AUTHOR), Mahdavi Sharif, Pouya1 (AUTHOR), Behfar, Maryam1 (AUTHOR), Shojaei, Sahar2 (AUTHOR), Shoae-Hassani, Alireza3 (AUTHOR), Jafari, Leila1 (AUTHOR), Khosravi, Abbas1 (AUTHOR), Nikfetrat, Zeynab1 (AUTHOR), Hamidieh, Amir Ali1 (AUTHOR) aahamidieh@tums.ac.ir
Publikováno v:
Scientific Reports. 9/9/2024, Vol. 14 Issue 1, p1-12. 12p.
Autor:
S. K. Zyryanov, I. N. Dyakov
Publikováno v:
Фармакоэкономика, Vol 17, Iss 2, Pp 129-136 (2024)
Objective: to conduct a clinical and economic study of acalabrutinib for the treatment of adult patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy in the Russian Federation.Material and
Externí odkaz:
https://doaj.org/article/338b38071e0947d4a72c818883742e92
Publikováno v:
International Journal of General Medicine, Vol Volume 17, Pp 2967-2979 (2024)
Honggang Guo,1,* Yabin Cui,2,* Yanliang Bai,1 Fan Yan,1 Wenhui Zhang,1 Yuqing Chen,1,* Mingyue Shi1,* 1Department of Hematology, Zhengzhou University People’s Hospital and Henan Provincial People’s Hospital, Zhengzhou, People’s
Externí odkaz:
https://doaj.org/article/ef942d27645540179a2a8b66e4e2a8d0
Autor:
Thomas, Caitlin1 (AUTHOR) caitlin.thomas@evidera.com, Marsh, Kevin1 (AUTHOR), Trapali, Myrto1 (AUTHOR), Krucien, Nicolas1 (AUTHOR), Worth, Gavin2 (AUTHOR), Cockrum, Paul3 (AUTHOR), Lycett, Debra3 (AUTHOR)
Publikováno v:
Cancer Medicine. Oct2024, Vol. 13 Issue 19, p1-12. 12p.
Autor:
Darçın, Tahir1 tahirdarcin@yahoo.com, Serin, İstemi2, Ugur, Mehmet Can3, Ekinci, Ömer4, Hindilerden, İpek Yonal5, Akpınar, Seval6, Hacıbekiroglu, Tuba7, Demircioğlu, Sinan8, Gültürk, Emine9, Albayrak, Murat10, Aydoğdu, İsmet11, Dal, Mehmet Sinan1, Doğu, Mehmet Hilmi12, Namdaroğlu, Sinem3, Doğan, Ali13, Nalçaci, Meliha5, Turgut, Burhan6, Başcı, Semih1, Altuntaş, Fevzi14
Publikováno v:
Hitit Medical Journal. Jun2024, Vol. 6 Issue 2, p186-192. 7p.
Autor:
Mott, David John (AUTHOR), Hitch, Jake (AUTHOR), Nier, Samantha (AUTHOR), Pemberton-Whiteley, Zack (AUTHOR), Skedgel, Chris (AUTHOR)
Publikováno v:
Patient Preference & Adherence. Jun2024, Vol. 18, p1243-1255. 13p.